- AHSR Published Abstract “A collaborative opioid prescribing (CoOP) model linking opioid treatment programs with office-based buprenorphine providers” (October 2014)
- AT Forum article on CoOp model “OTPs Can Help Support Primary Care Buprenorphine Prescribers” (October 9, 2015)
- ATTC Messenger “Addressing the Prescription Opioid and Heroin Crisis” Authored By: Michael Botticelli – Director of National Drug Control Policy (September 2015)
- CoOP Model Example – Currently at Use at Johns Hopkins Medicine
- CoOp Poster – “Increasing Office-Based Buprenophine Availability and Efficacy through Coordination with Opioid Treatment Programs”
Authors: Kenneth Stoller, MD; Christopher Louie, MPH; Mary Ann Stephens, PhD - Dear Obot Physician Leader Letter
- Frequently Asked Questions

AATOD...Follow Us 💫


















The Evolving Field of Opioid Treatment
AATOD proudly presents the world’s premier training conference event for the treatment of Opioid Use Disorder.
Early Registration Deadline: June 30, 2025
www.aatodconference.com
It’s Here…Conference Workshop Lineup!
View the comprehensive workshop listing and descriptions of the conference sessions.
Marketing & Advertising Opportunities
Exhibits & Sponsorship
Don’t miss out on the chance to show your support, share your products/services and secure your sponsorship at the AATOD 2025 Conference. You can now purchase exhibit booths, select sponsorship opportunities and register badges directly through the portal HERE. You can also learn more about exhibit opportunities and benefits on our conference website.
AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014
Contact Us
Phone
: 212-566-5555
Email
: info@aatod.org